G. Farkas et al., SUCCESSFUL SIMULTANEOUS TRANSPLANTATION OF KIDNEY AND FETAL PANCREATIC-ISLET MASSES, Transplant international, 8(3), 1995, pp. 229-233
This paper reports our experience with the successful simultaneous tra
nsplantation of kidney and fetal pancreatic islets in a 46-year-old di
abetic man. No detectable C-peptide level was noted and the end-stage
nephropathy required hemodialyis. The cadaver kidney and two masses of
8-week-cultured fetal islets were grafted simultaneously. After revas
cularization of the kidney, the islet masses were placed under the kid
ney capsule. Following transplantation, islet function was demonstrate
d by a higher C-peptide level, which subsequently persisted, Twenty-fo
ur months after grafting, islet function was provoked by glucagon and
glucose, which led to elevations in the C-peptide and insulin levels.
The insulin requirement fell from 58 to 24 U/day during the post-trans
plant period of 24 months. The mean value of HbA(1c) (5.6 % +/- 0.3 %)
indicated a constantly normal carbohydrate metabolism. Improvements i
n retinopathy were also noted. Three periods of kidney rejection were
diagnosed, but these proved reversible with high-dose steroid treatmen
t. The serum and urine beta-2-microglobulin levels correlated well wit
h rejection and recovery. More than 2 years after grafting, kidney fun
ction is in the normal range. On sonography, the transplanted islet ma
sses were repeatedly clearly visible, and 24 months following transpla
ntation the volume was twice the original one. The results indicate th
at simultaneous kidney and fetal pancreatic islet grafting is advantag
eous in end-stage nephropathy secondary to type I diabetes mellitus.